## Gene Summary
PIGB, or Phosphatidylinositol Glycan Anchor Biosynthesis Class B, is a gene involved in the biosynthesis of glycosylphosphatidylinositol (GPI) anchors. These anchors are critical for attaching proteins to the cell membrane, influencing various cellular processes such as signal transduction, cell adhesion, and immune response. The PIGB gene is broadly expressed in many tissues, with significant roles in normal cellular functions and development.

## Gene Drugs, Diseases, Phenotypes, and Pathways
Mutations and alterations in the PIGB gene have been associated with certain genetic disorders, specifically those affecting GPI anchor biosynthesis. Deficiencies can lead to GPI anchor deficiencies, which are grouped under a category of diseases known as congenital disorders of glycosylation. These disorders typically manifest with multi-organ impacts, including developmental issues, neurological deficits, and immune system malfunctions. Pathways involving PIGB are primarily the glycosylphosphatidylinositol(GPI)-anchor biosynthesis pathway, crucial for cell surface presentation of various proteins.

## Pharmacogenetics
Currently, there are no well-documented pharmacogenetic associations involving the PIGB gene that affect drug response or metabolism directly. The gene's primary influence remains within the realm of genetic and rare diseases rather than specific drug interactions or responses. However, understanding the function of GPI anchors and their biosynthetic pathways could possibly suggest future targets for therapeutic intervention in diseases caused by GPI anchor deficiencies. Further research may reveal more about potential drug targets or pharmacogenetic interactions related to PIGB.